Improving survival in ACLF: growing evidence for use of G-CSF.
作者信息
Simonetto D A, Shah V H, Kamath P S
机构信息
Mayo Clinic Gastroenterology and Hepatology, 200 First St. S.W., Rochester, MN, 55905, USA.
出版信息
Hepatol Int. 2017 Nov;11(6):473-475. doi: 10.1007/s12072-017-9834-x. Epub 2017 Nov 9.
Abstract
摘要
相似文献
1
Improving survival in ACLF: growing evidence for use of G-CSF.改善急性肝衰竭患者的生存率：使用粒细胞集落刺激因子的证据不断增加。
Hepatol Int. 2017 Nov;11(6):473-475. doi: 10.1007/s12072-017-9834-x. Epub 2017 Nov 9.
2
Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.粒细胞集落刺激因子治疗慢加急性肝衰竭患者的疗效：提高生存率，减轻肝损伤。
Hepatol Int. 2017 Nov;11(6):540-546. doi: 10.1007/s12072-017-9814-1. Epub 2017 Aug 24.
3
Granulocyte-colony stimulating factor in acute-on-chronic liver failure: Systematic review and meta-analysis of randomized controlled trials.粒细胞集落刺激因子治疗慢加急性肝衰竭的随机对照试验的系统评价和荟萃分析。
Gastroenterol Hepatol. 2023 May;46(5):350-359. doi: 10.1016/j.gastrohep.2022.09.007. Epub 2022 Sep 27.
4
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).粒细胞集落刺激因子（G-CSF）治疗慢加急性肝衰竭：一项多中心随机试验（GRAFT 研究）。
J Hepatol. 2021 Dec;75(6):1346-1354. doi: 10.1016/j.jhep.2021.07.033. Epub 2021 Aug 5.
5
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.粒细胞集落刺激因子治疗慢加急性肝衰竭的现状。
Semin Liver Dis. 2021 Aug;41(3):298-307. doi: 10.1055/s-0041-1723034. Epub 2021 May 15.
6
Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis.粒细胞集落刺激因子用于慢性肝衰竭急性发作：系统评价与荟萃分析
Ann Hepatol. 2015 Sep-Oct;14(5):631-41.
7
Effects of granulocyte-colony stimulating factor (G-CSF) on stem cell mobilization in patients with liver failure.粒细胞集落刺激因子（G-CSF）对肝衰竭患者干细胞动员的影响。
Eur J Intern Med. 2016 Dec;36:e37-e39. doi: 10.1016/j.ejim.2016.09.006. Epub 2016 Oct 13.
8
The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis.粒细胞集落刺激因子治疗慢加急性肝衰竭的疗效和安全性的系统评价和荟萃分析。
PLoS One. 2023 Nov 30;18(11):e0294818. doi: 10.1371/journal.pone.0294818. eCollection 2023.
9
Effectiveness of granulocyte colony-stimulating factor for patients with acute-on-chronic liver failure: a meta-analysis.粒细胞集落刺激因子治疗慢加急性肝衰竭患者的有效性：一项荟萃分析。
Ann Saudi Med. 2021 Nov-Dec;41(6):383-391. doi: 10.5144/0256-4947.2021.383. Epub 2021 Dec 2.
10
Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.粒细胞集落刺激因子动员 CD34(+) 细胞并提高慢加急性肝衰竭患者的生存率。
Gastroenterology. 2012 Mar;142(3):505-512.e1. doi: 10.1053/j.gastro.2011.11.027. Epub 2011 Nov 23.
引用本文的文献
1
The Impact of Liver Failure on the Immune System.肝脏衰竭对免疫系统的影响。
Int J Mol Sci. 2024 Sep 1;25(17):9522. doi: 10.3390/ijms25179522.
2
Granulocyte Colony-stimulating Factor Improves Innate Immunity in Pediatric Pretransplant Patients.粒细胞集落刺激因子可改善小儿移植前患者的先天免疫。
J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101282. doi: 10.1016/j.jceh.2023.09.003. Epub 2023 Sep 15.
3
The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing.系统性炎症和免疫抑制性慢加急性肝衰竭的机制及单细胞测序的应用前景。
J Immunol Res. 2022 Nov 2;2022:5091275. doi: 10.1155/2022/5091275. eCollection 2022.
4
Therapeutic Effect and Safety of Granulocyte Colony-Stimulating Factor Therapy for Acute-On-Chronic Liver Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.粒细胞集落刺激因子治疗急性慢性肝衰竭的疗效与安全性：一项随机对照试验的系统评价和荟萃分析
Front Med (Lausanne). 2021 Nov 16;8:784240. doi: 10.3389/fmed.2021.784240. eCollection 2021.
5
Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure.HBV 相关慢加急性肝衰竭患者循环中性粒细胞功能障碍
Front Immunol. 2021 Feb 25;12:620365. doi: 10.3389/fimmu.2021.620365. eCollection 2021.
6
Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure.白细胞、全身性炎症与慢加急性肝衰竭的免疫病理
Cells. 2020 Dec 8;9(12):2632. doi: 10.3390/cells9122632.
7
Approaches for patients with very high MELD scores.针对终末期肝病模型（MELD）评分极高的患者的治疗方法。
JHEP Rep. 2019 Feb 23;1(1):53-65. doi: 10.1016/j.jhepr.2019.02.008. eCollection 2019 May.
8
Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'.粒细胞集落刺激因子疗法在肝硬化中的作用，“任何深入的探寻之中都蕴含着答案” 。
J Clin Transl Hepatol. 2019 Dec 28;7(4):371-383. doi: 10.14218/JCTH.2019.00034. Epub 2019 Oct 22.
9
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.白细胞介素-22 通过重编程小鼠受损的再生途径改善慢性肝衰竭急性发作。
J Hepatol. 2020 Apr;72(4):736-745. doi: 10.1016/j.jhep.2019.11.013. Epub 2019 Nov 29.
10
Pathogenesis of Acute-on-Chronic Liver Failure in Patients With Infection.感染患者中急性-on-慢性肝衰竭的发病机制。
Clin Liver Dis (Hoboken). 2019 Oct 9;14(3):103-106. doi: 10.1002/cld.826. eCollection 2019 Sep.
本文引用的文献
1
Sepsis in alcohol-related liver disease.酒精性肝病相关的脓毒症。
J Hepatol. 2017 Nov;67(5):1031-1050. doi: 10.1016/j.jhep.2017.06.013. Epub 2017 Jun 22.
2
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.《急性-on-慢性肝衰竭：亚太肝脏研究协会（APASL）2014年共识推荐》
Hepatol Int. 2014 Oct;8(4):453-71. doi: 10.1007/s12072-014-9580-2. Epub 2014 Sep 26.
3
Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.粒细胞集落刺激因子和促红细胞生成素联合治疗改善失代偿期肝硬化患者的结局。
Gastroenterology. 2015 Jun;148(7):1362-70.e7. doi: 10.1053/j.gastro.2015.02.054. Epub 2015 Mar 4.
4
A case of granulocyte-colony stimulating factor/plasmapheresis-induced activation of granulocyte-colony stimulating factor-positive hepatic progenitors in acute-on-chronic liver failure.1例慢性肝衰竭急性发作患者中粒细胞集落刺激因子/血浆置换诱导粒细胞集落刺激因子阳性肝祖细胞激活的病例
Hepatology. 2015 Aug;62(2):649-52. doi: 10.1002/hep.27708. Epub 2015 Apr 8.
5
Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.粒细胞集落刺激因子治疗重症酒精性肝炎：一项随机初步研究。
Am J Gastroenterol. 2014 Sep;109(9):1417-23. doi: 10.1038/ajg.2014.154. Epub 2014 Jun 17.
6
Toward an improved definition of acute-on-chronic liver failure.迈向对慢加急性肝衰竭更完善的定义。
Gastroenterology. 2014 Jul;147(1):4-10. doi: 10.1053/j.gastro.2014.05.005. Epub 2014 May 20.
7
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.慢性加急性肝衰竭患者经粒细胞集落刺激因子（G-CSF）治疗后树突状细胞和 IFN-γ 分泌 T 细胞的频率改变。
Liver Int. 2014 Apr;34(4):505-13. doi: 10.1111/liv.12415.
8
Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure.粒细胞集落刺激因子治疗可改善乙型肝炎病毒相关慢加急性肝衰竭患者的生存。
World J Gastroenterol. 2013 Feb 21;19(7):1104-10. doi: 10.3748/wjg.v19.i7.1104.
9
Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.粒细胞集落刺激因子动员 CD34(+) 细胞并提高慢加急性肝衰竭患者的生存率。
Gastroenterology. 2012 Mar;142(3):505-512.e1. doi: 10.1053/j.gastro.2011.11.027. Epub 2011 Nov 23.
10
Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.粒细胞集落刺激因子诱导酒精性脂肪性肝炎中肝祖细胞的增殖：一项随机试验。
Hepatology. 2008 Jul;48(1):221-9. doi: 10.1002/hep.22317.
Zotero 插件